Abstract
Introduction
Tobacco use worsens gastrointestinal reflux disease (GERD). Smoking cessation improves GERD symptoms, but its impact on the efficacy of laparoscopic anti-reflux surgery (LARS) is unclear. In this retrospective cohort study, we hypothesized that non-smokers would demonstrate greater long-term improvements in disease-specific quality of life than active smokers.
Methods
Data were maintained in an IRB-approved prospective database, and patients were stratified according to tobacco use. Postoperative follow-up occurred in clinic and long-term follow-up via telephone interview. Outcomes measured were gastroesophageal health-related quality of life (GERD-HRQL) and GERD symptom scale (GERSS) scores, proton pump inhibitor (PPI) cessation, and satisfaction with surgery.
Results
Two hundred and thirty-five patients underwent primary LARS, and 31 (13%) were active smokers with 18 median pack-years [10–30]. Baseline PPI use (96% vs. 94%, p = 0.64), presence of a hiatal hernia (79% vs. 68%, p = 0.13), esophagitis (28% vs. 45%, p = 0.13), and DeMeester score (41.9 vs. 33.6, p = 0.47) were similar. Baseline GERD-HRQL and GERSS scores and their post-surgical decreases were also similar between groups. PPI cessation was achieved in 92% of non-smokers and 94% of smokers (p = 0.79), and GERD-HRQL scores decreased to 4 [1–7] and 5 [0–12], respectively (p = 0.53). After 59 [25–74] months, GERD-HRQL scores were 5 [2–11] and 2 [0–13] (p = 0.61) and PPI cessation was maintained in 69% and 79% of patients (p = 0.59). Satisfaction with surgery was similar between smokers and non-smokers (88% vs. 87%, p = 0.85). Female gender was significantly associated with increased improvements in GERD-HRQL (p < 0.01) and GERSS scores (p = 0.04) postoperatively but not at long-term follow-up. Patients without a hiatal hernia were less likely to achieve long-term PPI cessation compared to those with a hernia (OR 0.23, p < 0.01).
Conclusions
After 5 years, smokers demonstrate similar symptom resolution, PPI cessation rates, and satisfaction with surgery as non-smokers. Active smoking does not appear to negatively impact long-term symptomatic outcomes of LARS.
Similar content being viewed by others
References
Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R, Group GC (2006) The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 101:1900–1920; quiz 1943
El-Serag HB, Sweet S, Winchester CC, Dent J (2014) Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 63:871–880
Stefanidis D, Hope WW, Kohn GP, Reardon PR, Richardson WS, Fanelli RD, Committee SG (2010) Guidelines for surgical treatment of gastroesophageal reflux disease. Surg Endosc 24:2647–2669
Galmiche JP, Hatlebakk J, Attwood S, Ell C, Fiocca R, Eklund S, Långström G, Lind T, Lundell L, Collaborators LT (2011) Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial. JAMA 305:1969–1977
Lundell L, Miettinen P, Myrvold HE, Hatlebakk JG, Wallin L, Malm A, Sutherland I, Walan A, Group NGS (2007) Seven-year follow-up of a randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux oesophagitis. Br J Surg 94:198–203
Mehta S, Bennett J, Mahon D, Rhodes M (2006) Prospective trial of laparoscopic nissen fundoplication versus proton pump inhibitor therapy for gastroesophageal reflux disease: Seven-year follow-up. J Gastrointest Surg 10:1312–1316; discussion 1316–1317
Ness-Jensen E, Lagergren J (2017) Tobacco smoking, alcohol consumption and gastro-oesophageal reflux disease. Best Pract Res Clin Gastroenterol 31:501–508
Velanovich V, Vallance SR, Gusz JR, Tapia FV, Harkabus MA (1996) Quality of life scale for gastroesophageal reflux disease. J Am Coll Surg 183:217–224
Anvari M, Allen C, Marshall J, Armstrong D, Goeree R, Ungar W, Goldsmith C (2006) A randomized controlled trial of laparoscopic nissen fundoplication versus proton pump inhibitors for treatment of patients with chronic gastroesophageal reflux disease: one-year follow-up. Surg Innov 13:238–249
Schmid M, Sood A, Campbell L, Kapoor V, Dalela D, Klett DE, Chun FK, Kibel AS, Sammon JD, Menon M, Fisch M, Trinh QD (2015) Impact of smoking on perioperative outcomes after major surgery. Am J Surg 210:221–229.e226
Sørensen LT (2012) Wound healing and infection in surgery. The clinical impact of smoking and smoking cessation: a systematic review and meta-analysis. Arch Surg 147:373–383
Sørensen LT (2012) Wound healing and infection in surgery: the pathophysiological impact of smoking, smoking cessation, and nicotine replacement therapy: a systematic review. Ann Surg 255:1069–1079
Menezes MA, Herbella FAM (2017) Pathophysiology of gastroesophageal reflux disease. World J Surg 41:1666–1671
Eusebi LH, Ratnakumaran R, Yuan Y, Masoud SD, Bazzoli F, Ford AC (2018) Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Gut 67:430–440
Ness-Jensen E, Lindam A, Lagergren J, Hveem K (2014) Tobacco smoking cessation and improved gastroesophageal reflux: a prospective population-based cohort study: the HUNT study. Am J Gastroenterol 109:171–177
Chrysos E, Athanasakis E, Pechlivanides G, Tzortzinis A, Mantides A, Xynos E (2004) The effect of total and anterior partial fundoplication on antireflux mechanisms of the gastroesophageal junction. Am J Surg 188:39–44
Peters JH, DeMeester TR, Crookes P, Oberg S, de Vos SM, Hagen JA, Bremner CG (1998) The treatment of gastroesophageal reflux disease with laparoscopic Nissen fundoplication: prospective evaluation of 100 patients with "typical" symptoms. Ann Surg 228:40–50
Del Genio G, Tolone S, Del Genio F, D'Alessandro A, Brusciano L, Aggarwal R, Conzo G, Orditura M, Docimo L, Del Genio A (2012) Impact of total fundoplication on esophageal transit: analysis by combined multichannel intraluminal impedance and manometry. J Clin Gastroenterol 46:e1–5
Hoshino M, Omura N, Yano F, Tsuboi K, Yamamoto SR, Akimoto S, Kashiwagi H, Yanaga K (2016) Backflow prevention mechanism of laparoscopic Toupet fundoplication using high-resolution manometry. Surg Endosc 30:2703–2710
Little AG (1992) Mechanisms of action of antireflux surgery: theory and fact. World J Surg 16:320–325
Lin M, Gerson LB, Lascar R, Davila M, Triadafilopoulos G (2004) Features of gastroesophageal reflux disease in women. Am J Gastroenterol 99:1442–1447
Kim SY, Jung HK, Lim J, Kim TO, Choe AR, Tae CH, Shim KN, Moon CM, Kim SE, Jung SA (2019) Gender specific differences in prevalence and risk factors for gastro-esophageal reflux disease. J Korean Med Sci 34:e158
Kim SY, Kim N, Kim GH (2016) Sex and gender differences in gastroesophageal reflux disease. J Neurogastroenterol Motil 22:2093–2879
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Drs. Wang, Jalilvand, Chen, Vadlamudi, and Perry, and Mr. Gupta, have no conflicts of interest to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Wang, V.L., Jalilvand, A.D., Gupta, A. et al. Tobacco use is not associated with increased risk of recurrent reflux 5 years after laparoscopic anti-reflux surgery. Surg Endosc 35, 4771–4778 (2021). https://doi.org/10.1007/s00464-020-07956-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-020-07956-z